Validation of a survival-risk score (SRS) in relapsed/refractory CLL patients treated with idelalisib–rituximab

Massimo Gentile, Enrica Antonia Martino, Andrea Visentin, Marta Coscia, Gianluigi Reda, Paolo Sportoletti, Francesca Romana Mauro, Luca Laurenti, Marzia Varettoni, Roberta Murru, Annalisa Chiarenza, Ernesto Vigna, Francesco Mendicino, Eugenio Lucia, Sabrina Bossio, Anna Grazia Recchia, Riccardo Moia, Daniela Pietrasanta, Giacomo Loseto, Ugo ConsoliIlaria Scortechini, Francesca Maria Rossi, Antonella Zucchetto, Hamdi Al-Janazreh, Candida Vitale, Giovanni Tripepi, Graziella D’Arrigo, Ilaria Angeletti, Riccardo Bomben, Antonino Neri, Giovanna Cutrona, Gilberto Fronza, Francesco Di Raimondo, Gianluca Gaidano, Antonio Cuneo, Robin Foà, Manlio Ferrarini, Livio Trentin, Valter Gattei, Fortunato Morabito

Research output: Contribution to journalLetter

Original languageEnglish
Article number92
JournalBlood Cancer Journal
Volume10
Issue number9
DOIs
Publication statusPublished - Sep 1 2020

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this